Association of the shuffling of Streptococcus pyogenes clones and the fluctuation of scarlet fever cases between 2000 and 2006 in central Taiwan by Chiou, Chien-Shun et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Association of the shuffling of Streptococcus pyogenes clones and the 
fluctuation of scarlet fever cases between 2000 and 2006 in central 
Taiwan
Chien-Shun Chiou*1,2, You-Wun Wang1, Pei-Ling Chen3, Wan-Ling Wang1, 
Ping-Fuai Wu3 and Hsiao-Lun Wei1
Address: 1The Central Region Laboratory, Center for Research and Diagnostics, Centers for Disease Control, Taichung City 40855, Taiwan, 
2Institute of Medicine, Chung Shan Medical University, Taichung City 40201, Taiwan and 3The Second Division, Centers for Disease Control, 
Taichung City 40855, Taiwan
Email: Chien-Shun Chiou* - nipmcsc@cdc.gov.tw; You-Wun Wang - pleione@cdc.gov.tw; Pei-Ling Chen - peiling@cdc.gov.tw; Wan-
Ling Wang - r93b47307@cdc.gov.tw; Ping-Fuai Wu - f10282@cdc.gov.tw; Hsiao-Lun Wei - slwei@cdc.gov.tw
* Corresponding author    
Abstract
Background:  The number of scarlet fever occurrences reported between 2000 and 2006
fluctuated considerably in central Taiwan and throughout the nation. Isolates of Streptococcus
pyogenes were collected from scarlet fever patients in central Taiwan and were characterized by
emm sequencing and a standardized pulsed-field gel electrophoresis (PFGE) method. National
weekly report data were collected for investigating epidemiological trends.
Results: A total of 23 emm types were identified in 1,218 S. pyogenes isolates. The five most
prevalent emm types were emm12 (50.4%), emm4 (23.2%), emm1 (16.4%), emm6 (3.8%) and emm22
(3.0%). PFGE analysis with SmaI suggested that, with a few exceptions, strains with a common emm
type belonged to the same clone. There were two large emm12 clones, one with DNA resistant to
cleavage by SmaI. Each prevalent emm clone had major PFGE strain(s) and many minor strains. Most
of the minor strains emerged in the population and disappeared soon after. Even some major
strains remained prevalent for only 2–3 years before declining. The large fluctuation of scarlet fever
cases between 2000 and 2006 was associated with the shuffling of six prevalent emm clones. In
2003, the dramatic drop in scarlet fever cases in central Taiwan and throughout the whole country
was associated with the occurrence of a severe acute respiratory syndrome (SARS) outbreak that
occurred between late-February and mid-June in Taiwan.
Conclusion: The occurrences of scarlet fever in central Taiwan in 2000–2006 were primarily
caused by five emm types, which accounted for 96.8% of the isolates collected. Most of the S.
pyogenes strains (as defined by PFGE genotypes) emerged and lasted for only a few years. The
fluctuation in the number of scarlet fever cases during the seven years can be primarily attributed
to the shuffling of six prevalent emm clones and to the SARS outbreak in 2003.
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Background
Streptococcus pyogenes (Group A streptococcus) is a com-
mon pathogen responsible for a number of human sup-
purative infections, including pharyngitis, impetigo,
pyoderma, erysipelas, cellulitis, necrotizing fasciitis, toxic
streptococcal syndrome, scarlet fever, septicemia, pneu-
monia and meningitis. It also causes non-suppurative
sequelae, including acute rheumatic fever, acute glomeru-
lonephritis and acute arthritis [1]. Scarlet fever, character-
ized by a sore throat, skin rash and strawberry tongue, is
most prevalent in school children aged four to seven years
old. This disease was listed as a notifiable disease in Tai-
wan until 2007; as such, all cases of scarlet fever had to be
reported to the public heath department. According to our
records, however, only 9% of the medical centers, regional
hospitals and district hospitals in central Taiwan reported
cases of scarlet fever to the health authorities between
1996 and 1999. The number of scarlet fever cases is there-
fore likely to be significantly underreported. Scarlet fever
outbreaks frequently occur in young children at day-care
centers, kindergartens and elementary schools [2,3] and
also occur in adults upon exposure to contaminated food
[4].
Genotyping bacterial isolates with various methods is fre-
quently used to compare the genetic relatedness of bacte-
rial strains and provides useful information for
epidemiological studies. In a previous study, we used emm
(gene of M protein) sequencing [5], vir typing [6] and
pulsed-field gel electrophoresis (PFGE) typing to analyze
a collection of streptococcal isolates from scarlet fever
patients and used these data to build a DNA fingerprint
and emm sequence database for long-term disease surveil-
lance [7]. Vir typing has since been abandoned in our lab
because it has lower discriminatory power than PFGE and
the protocol is difficult to standardize with conventional
agarose gel electrophoresis. In contrast, the PFGE protocol
for S. pyogenes has been standardized in our laboratory,
and a second enzyme, SgrAI, has been found to replace
SmaI for analysis of strains with DNA resistant to SmaI
digestion [7]. Since PFGE is highly discriminative and
emm sequencing provides unambiguous sequence infor-
mation regarding emm type, we adopted these two geno-
typing methods to characterize streptococcal isolates and
build a Streptococcus pyogenes DNA fingerprint and
sequence database for the long-term study of scarlet fever
and other streptococcal diseases.
The number of scarlet fever cases in central Taiwan fluctu-
ated greatly between 2000 and 2006. Relative to the
number of scarlet fever occurrences in 2000, occurrences
increased in 2001 and doubled in 2002, but dramatically
dropped in 2003. The number of occurrences increased
again since 2004. In this study, we characterized 1,218
isolates collected between 2000–2006 by emm sequencing
and PFGE. The bacterial genotyping data and the epidemi-
ological data collected via the Notifiable Disease Report-
ing System (established by Taiwan Centers for Disease
Control (Taiwan CDC)) were used to examine the signifi-
cant fluctuation in the number of scarlet fever cases
between 2000 and 2006.
Results
Epidemiological trend of scarlet fever
Taiwan is an island country populated by 22.9 million
people, most of whom reside in the western region (Figure
1A). The population in northern, central, southern, and
eastern areas is 10.2, 5.7, 6.4 and 0.6 million, respectively.
Nationwide information for all notifiable diseases has
been systematically collected since 2000. For accurate
analysis, the number of confirmed scarlet fever cases was
adjusted by multiplying the number of reported cases and
the specimen positive rate. The total, adjusted number of
confirmed cases throughout the whole country increased
from 716 cases in 2000 to 1,258 in 2002, but dramatically
dropped to 771 in 2003 (Table 1). This number increased
again in 2004 and, in 2005, reached the high levels seen
in 2002. However, the number of cases slightly declined
again in 2006. In central Taiwan, the epidemiological
trend was similar to the national profile, but fluctuated
more dramatically between 2000 and 2004. While the
number of scarlet fever cases was 142 in 2000, this
number doubled in 2002 but then dropped in 2003 to the
levels seen in 2000 (Table 1). The number of cases
increased again in 2004 and, in 2006, reached the levels
seen in 2002. The number of cases in 2006 was greater
than that in 2005 and differed from the national trend.
The number of cases in central Taiwan accounted for 18%
to 24% of cases throughout the whole country.
The profiles of weekly reported cases revealed that scarlet
fever was more prevalent in the winter and spring seasons
(2nd – 25th weeks) in 2000–2006. However, there was a
remarkable decrease in the number of cases in the 6th and
7th weeks (Figure 1B). This decrease may be due to the
long holiday of the traditional lunar New Year and winter
break from school, as it is usually from late-January to
mid-February (4th  – 7th  weeks). The weekly reported
number of scarlet fever cases in 2002 was mostly higher
than the weekly average from 2000 to 2006 (Figure 1B).
In 2003, except in the 11th week, the number of weekly
reported cases in the first 16 weeks was greater than the
average. Furthermore, the number of cases between the 4th
and 9th weeks was even higher than that in 2002. After the
16th week, the number of cases in 2003 was below the
overall average and was significantly decreased from the
17th to 24th week (mid-April to mid-June). A lower level of
reported cases lasted until the first half of year 2004. In
early 2003, a severe acute respiratory syndrome (SARS)
outbreak occurred in Taiwan. There were two stages forBMC Microbiology 2009, 9:115 http://www.biomedcentral.com/1471-2180/9/115
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(A) Map of Taiwan and population density (B) National weekly reported cases of scarlet fever between 2000 and 2006 Figure 1
(A) Map of Taiwan and population density (B) National weekly reported cases of scarlet fever between 2000 
and 2006. The total average throughout 2000–2006 is indicated by a red dashed line. The two stages of the SARS epidemic in 
2003 are marked by blue (stage I) and red (stage II) bars.
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Table 1: Reported and adjusted confirmed scarlet fever cases in the whole country and in central Taiwan from 2000 to 2006.
Category 2000 2001 2002 2003 2004 2005 2006
Nationwide
Reported cases (A) 924 1143 1655 1162 1254 1713 1635
Specimens collected (B) 659 792 1359 964 1100 1614 1594
Sampling rate % (B/A) 71% 69% 82% 83% 88% 94% 97%
Laboratory confirmed cases (C) 511 574 1033 640 759 1132 1130
Positive rate % (C/B) 78% 72% 76% 66% 69% 70% 71%
Adjusted confirmed cases (A × C/B) 716 828 1258 771 865 1201 1159
Central region
R e p o r t e d  c a s e s  ( A )1 6 12 1 83 3 21 9 72 3 13 0 73 5 7
Specimens collected (B) 129 199 307 182 219 305 355
Sampling rate % (B/A) 80% 91% 92% 92% 95% 99% 99%
Laboratory confirmed cases (C) 114 146 260 135 156 216 272
Positive rate % (C/B) 88% 73% 85% 74% 71% 71% 77%
Adjusted confirmed cases (A ×  C / B )1 4 21 6 02 8 11 4 61 6 52 1 72 7 4
% of central region/nationwide 20% 19% 22% 19% 19% 18% 24%
Isolates collected for analysis 139 154 273 122 115 174 241BMC Microbiology 2009, 9:115 http://www.biomedcentral.com/1471-2180/9/115
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the SARS epidemic: stage I occurred from late-February to
mid-April (9th – 16th week), with scattered sporadic cases,
and stage II occurred between mid-April and mid-June
(17th – 24th week), with severe nosocomial infections in
several hospitals. The dramatic decline of scarlet fever
notifications in 2003 occurred during the stage II period
of the SARS epidemic.
Distribution of emm types among isolates collected in 
central Taiwan
For each year between 2000 and 2006, 115 to 273 isolates
were collected for genotyping in central Taiwan (Table 1).
A total of 1,218 isolates were characterized to investigate
the distribution of emm types. In total, 23 emm types were
identified in the isolates. The five most prevalent emm
types, accounting for 96.8% of the collection, were emm12
(50.4%), emm4 (23.2%), emm1 (16.4%), emm6 (3.8%)
and emm22 (3.0%) (Table 2). emm12 was the predomi-
nant type found between 2000–2001, accounting for
87.1% and 57.1% of the total isolates in 2000 and 2001,
respectively. It became the predominant type again in
2005 and 2006, accounting for 69.3% of the isolates in
2006. emm1 was predominant in 2002, emm4 was most
prevalent in 2003 and 2004, and emm6 emerged in 2001
but was not detected again after 2003.
PFGE and emm genotypes
The 1,218 S. pyogenes isolates were analyzed by PFGE with
SmaI to investigate the clonal relationship among the iso-
lates. There were 127 isolates with DNA resistant to SmaI
digestion, and their pattern (with only one DNA band)
was referred to as a SPYS16.0026 PFGE-SmaI type. The
127 isolates with the SPYS16.0026 genotype were further
analyzed by digestion with SgrAI. The genetic relatedness
of the bacterial strains was evaluated by the levels of sim-
ilarity among the PFGE-SmaI patterns. A dendrogram was
constructed using the Unweighted Pair Group Method
with Arithmatic mean (UPGMA) algorithm. The dendro-
gram revealed that all of the emm4 and emm6 isolates, as
well as the majority of emm1 and emm22 isolates, were
each distributed in a unique cluster. However, the emm12
isolates were located in two distinct clusters and two sin-
gletons (Figure 2). One of these clusters included 125
emm12 isolates that were resistant to SmaI digestion. Clus-
tering analysis indicated that isolates with a common emm
type were, in general, more closely related than those with
different emm  types. However, there were a few excep-
tions. Two strains with different emm types (emm101 and
st5282) had indistinguishable PFGE-SmaI patterns, and a
strain with a stIL103 type was located within the emm1
cluster (Figure 2). stIL103 is an allele of emm1 that lacks
the codons encoding the mature M1 7–24 residues (http:/
/www.cdc.gov/ncidod/biotech/strep/strepindex.htm;
accessed on April 20th, 2009). Sequence analysis suggests
that the st5282 strain could be derived from an emm101
strain via emm gene recombination, as the sequence for
the first 26 codons of the st5282 gene were identical to
that for the emm101 gene. Two emm12 and one emm22
isolates were distant from the major emm12 and emm22
clusters (Figure 2). The 127 SmaI-resistant isolates were
identified to be of emm12, emm1 or emm58 type.
In total, 94 emm:PFGE-SmaI genotypes were identified in
the 1,218 isolates. Eight major emm:PFGE genotypes,
emm1:SPYS16.0022 (14.9%), emm4:SPYS16.0006
(11.7%),  emm4:SPYS16.0008 (8.1%),
emm4:SPYS16.0083 (2.6%), emm6:SPYS16.0020 (2.7%),
emm12:SPYS16.0013 (29.6%), emm12:SPYS16.0026
(10.3%) and emm12:SPYS16.0087 (2.3%), made up
82.2% of the 1,218 isolates. Five of the major emm:PFGE
genotypes were detected throughout the seven years stud-
ied. In contrast, most emm:PFGE genotypes lasted for only
1–2 years; they emerged in the population and quickly
disappeared.
The 127 SmaI-resistant isolates were discriminated by
PFGE with SgrAI into 14 emm12:PFGE-SgrAI, 1
emm1:PFGE and 1 emm58:PFGE types. The 125 emm12
Table 2: Distribution of emm types in Streptococcus pyogenes isolates collected in central Taiwan from 2000 to 2006
emm Type Number (%) of isolates in year Total
2000 2001 2002 2003 2004 2005 2006
emm12 121 (87.1) 88 (57.1) 64 (23.4) 17 (13.9) 45 (39.1) 112 (64.4) 167 (69.3) 614 (50.4)
emm4 11 (7.9) 21 (13.6) 58 (21.2) 54 (44.3) 57 (49.6) 39 (22.4) 43 (17.8) 283 (23.2)
emm1 4 (2.9) 35 (22.7) 111 (40.7) 26 (21.3) 9 (7.8) 10 (5.7) 5 (2.1) 200 (16.4)
emm6 0 (0.0) 6 (3.9) 26 (9.5) 14 (11.5) 0 (0.0) 0 (0.0) 0 (0.0) 46 (3.8)
emm22 1 (0.7) 1 (0.6) 2 (0.7) 1 (0.8) 3 (2.6) 10 (5.7) 18 (7.5) 36 (3.0)
Other* 2 (1.4) 3 (1.9) 12 (4.4) 10 (8.2) 4 (3.5) 0 (0.0) 8 (3.3) 39 (3.2)
Total 139 154 273 122 115 174 241 1218
*18 emm types: emm2 (5 isolates), emm11 (11), emm28 (1), emm49 (5), emm58 (1), emm76 (1), emm77 (1), emm81 (1), emm82 (1), emm89 (3), 
emm92 (1), emm101 (1), emm102 (1), emm103 (1), st2904 (2), st5282 (1), stG485 (1), stIL103 (1)BMC Microbiology 2009, 9:115 http://www.biomedcentral.com/1471-2180/9/115
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Dendrogram constructed with PFGE-SmaI patterns, with their corresponding emm types and number of isolates obtained  between 2000 and 2006 Figure 2
Dendrogram constructed with PFGE-SmaI patterns, with their corresponding emm types and number of iso-
lates obtained between 2000 and 2006. The clustering analysis was performed with BioNumerics using the UPGMA algo-
rithm and the value of Dice predicted similarity of two patterns at settings of 1% optimization and 0.7% position tolerance.
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isolates were distributed in two distinct clusters, A and B
(Figure 3). Strains within cluster A were quite divergent,
with the most divergent types sharing only 65% pattern
similarity.
Distribution of prevalent emm clones over time
In this study, a cluster of strains (as defined by PFGE
types) having a common emm type and sharing higher
PFGE pattern similarity than others with different emm
types were considered to belong to a common emm clone.
The stIL103 strain is an exception to this, as it shared high
PFGE pattern similarity with the cluster of emm1 strains
and was therefore considered to be part of the emm1
clone. Based on the groupings made by the PFGE patterns,
six major emm (emm1, emm4, emm6, emm12, emm12* and
emm22) clones were identified and are shown in Figure 2.
The  emm12* clone represents the emm12 strains with
DNA resistant to SmaI digestion. The six major emm
clones made up 96.5% of the 1,218 isolates. The adjusted
number of the annual confirmed cases of scarlet fever in
central Taiwan ranged from 142 to 282 between 2000 and
2006 (Table 1), and 115 to 273 isolates were collected
each year for genotyping. The number of isolates geno-
typed was adjusted to the number of annual confirmed
cases to investigate the association of the fluctuation of
scarlet fever cases and the relative prevalence of the emm
clones. As shown in Figure 4, the emm12* and emm12
clones were the most prevalent in 2000. The two clones
declined over time and were at their lowest levels in 2003.
The emm1 clone was the most prevalent in 2002 and the
emm4 clone was predominant in 2003 and 2004. In 2001,
although the number of emm12* and emm12 clones
declined, the number of emm1 clones increased signifi-
cantly. The total number of scarlet fever cases in 2002 was
doubled that in 2000 and were primarily attributed to an
increase in the number of the emm1, emm4 and emm6
clones. The number of cases in 2003 was considerably
lower than that in 2002, likely due to a decline in all
major clones except for emm4. The number of cases
increased significantly again in 2005, and this increase is
associated with a dramatic rise in the prevalence of the
emm12 clone.
Dendrogram constructed with PFGE-SgrAI patterns, with their corresponding emm types and number of isolates Figure 3
Dendrogram constructed with PFGE-SgrAI patterns, with their corresponding emm types and number of iso-
lates. DNA from these isolates was resistant to SmaI digestion. The clustering analysis was performed with BioNumerics using 
the UPGMA algorithm and the value of Dice predicted similarity of two patterns at settings of 1% optimization and 0.7% posi-
tion tolerance.
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Discussion
The cases of scarlet fever in central Taiwan from 2000 to
2006 were caused by S. pyogenes strains with a limited
number of emm types (Table 2). In fact, five prevalent emm
types represented 96.8% of the isolates causing scarlet
fever during this time period. Of the 23 emm types iso-
lated, 17 made up 99.4% of the isolates. These 17 types
were among the 30 most common emm types that caused
invasive streptococcal infections in the United States
between 2000 and 2004. Twelve of these types accounted
for 75.5% of the isolates characterized and were included
in the proposed 26-valent vaccine (emm types 1, 1.2, 2, 3,
5, 6, 11, 12, 14, 18, 19, 22, 24, 28, 29, 33, 43, 59, 75, 76,
77, 89, 92, 94, 101, and 114) [8].
In our previous work on 179 S. pyogenes isolates collected
in central Taiwan between 1996 and 1999, the five most
common emm types in central Taiwan remained the same,
but the frequency changed in the two time periods, 1996–
1999 and 2000–2006 [7]. However, the prevalence and
distribution of emm types could have geographic varia-
tion. Yan et al. [9] analyzed 77 S. pyogenes isolates col-
lected from scarlet fever patients between 1993 and 2002
in southern Taiwan and found only three emm  types
among the isolates, with emm1 being the most prevalent
type. Chen and colleagues characterized 830 isolates col-
lected between 2001 and 2002 in northern Taiwan and
found that the most frequent emm  types were emm1
(29.2%),  emm4 (24.1%), emm12 (19.0%), emm6
(15.8%), stIL103 (5.7%) and emm22 (1.9%) [10]. In our
study, the most common emm types in 427 isolates col-
lected in the same time period in central Taiwan were
emm12 (35.6%), emm1 (34.2%), emm4 (18.5%), emm6
(7.5%) and emm11 (0.9%). stIL103 was present in north-
ern Taiwan, but it was not found in the central region dur-
ing the same time period. Thus, the distribution and
frequency of emm types appear to be geographically varied
even in such a small country. The geographic variation in
the prevalence of emm clones may explain why the epide-
miological trend of scarlet fever in 2006 in central Taiwan
was different from that in the whole country.
The major emm types were further discriminated into a
number of PFGE types, and clustering analysis of the
PFGE patterns suggests that the emm1, emm6 and emm4
strains belong to a single clone. The emm12 strains belong
to two major clones and two singletons, and emm22
strains belong to one major clone and one singleton (Fig-
ure 2). Thus, six emm clones caused most (96.5%) of the
scarlet fever cases in central Taiwan during the seven year
Distribution of emm clones between 2000 and 2006 Figure 4
Distribution of emm clones between 2000 and 2006. The number of Streptococcus pyogenes isolates analyzed is adjusted 
according to the number of adjusted annual confirmed of cases.
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time period. The fluctuation of scarlet fever cases was asso-
ciated with the shuffling of the prevalent emm clones (Fig-
ure 4). The finding that only a few prevalent M (emm)
types caused most occurrences of scarlet fever in a specific
location in a given year period, as well as the shuffling of
predominant M types, has been observed in many epide-
miological studies in the early 20th century [11]. During
major epidemics of streptococcal infections in previous
years, only a few serotypes predominated, and the strains
were rich in M protein, encapsulated and were highly vir-
ulent [11]. Type-specific immunity was important for pre-
venting re-infection with the same M type. It is thought
that the shuffling of predominant M types is due to the
type-specific immunity, leading to the decline of infec-
tions with certain M types and the emergence of other vir-
ulent M types. In the present study, the prevalence of the
emm12*,  emm1 and emm6 clones both increased and
decreased within one year. In contrast, the emm12 and
emm4 clones persisted throughout the seven year period.
This phenomenon may be due to the fact that the emm12
and emm4 clones produced less M protein and were less
virulent than the emm12*, emm1 and emm6 clones.
The PFGE study also indicates that each of the six emm
clones has one predominant PFGE type, except for the
emm4 clone, which has two major PFGE types (Figure 2).
The less prevalent PFGE genotypes of each emm  clone
emerged and quickly disappeared. Even some major PFGE
genotypes, such as SPYS16.0026 of the emm12* clone,
SPYS16.0020 of the emm6 clone and SPYS16.0022 of the
emm1 clone, remained prevalent for only 2–3 years before
declining. However, the SPYS16.0013 genotype of the
emm12 clone did not follow this trend, as it was prevalent
throughout 2000–2006 and was most prevalent in 2006.
If a newly emerging strain can only prosper in a specific
location for a few years, then the emm12:SPYS16.0013
strains isolated during two different time periods should
be different. These differences may not be detectable by
PFGE analysis. Whether bacterial isolates that prevail for
two periods become genetically diversified is an interest-
ing subject and may be studied by other genotyping meth-
ods, such as single nucleotide polymorphism, by
virulence gene detection and by antimicrobial susceptibil-
ity testing.
The SPYS16.0026 isolates, with DNA resistant to SmaI
digestion, were found in three emm types, suggesting that
they have multiple evolutionary origins. Of the 127
SPYS16.0026 isolates, 125 belonged to the emm12 type.
The first isolate resistant to SmaI digestion was identified
in central Taiwan in 1998 and was an emm33 type. The
emm12:SPYS16.0026 strain was detected for the first time
in 1999 [7]. Our previous studies indicated that the
emm12:SPYS16.0026 strain is most likely derived from an
emm12:SPYS16.0013 strain by an insertion of a large DNA
fragment into the genome [7]. The large DNA segment
could have carried the gene(s) responsible for DNA meth-
ylation and resistance to cleavage by SmaI. These strains
were analyzed with SgrAI. Clustering analysis of the PFGE-
SgrAI patterns revealed diverse genetic relationships
among the emm12:SPYS16.0026 strains (Figure 3). The
high genetic divergence suggests that the
emm12:SPYS16.0026 strains have derived from multiple
origins. Recently, Euler et al. [12] have shown that resist-
ance to SmaI cleavage is due to the presence of a DNA
methyltransferase gene, which is carried on a mobile chi-
meric element that has transposon- and bacteriophage-
like characteristics. This mobile element may explain the
high genetic diversity among the SmaI-resistant strains
that emerged in such short period of time.
The fluctuation of scarlet fever cases between 2000 and
2006 may be partially explained by the shuffling of several
prevalent  emm  clones. However, the dramatic drop in
reported cases in 2003 is difficult to explain. In early
2003, Taiwan was badly hit by a severe SARS outbreak.
The SARS epidemic in Taiwan had two distinct stages,
with the beginning in the late-February (the 9th week) and
the second ending in mid-June [13]. The stage I epidemic
occurred from late-February to mid-April (the 9th to 16th
week) and consisted of only scattered, sporadic cases, with
most of the patients having recently traveled to China. In
this stage, the disease did not cause much panic and the
level of scarlet fever remained high. In stage II (from mid-
April to mid-June or the 17th to 24th week), several clusters
of infection occurred via intra-hospital or inter-hospital
transmission. Enormous panic spread over the whole
country after an outbreak of nosocomial infection was
confirmed on the 22nd of April. The disease was subse-
quently transmitted to several hospitals and spread from
the North to the South. The number of scarlet fever cases
dropped remarkably during this period. Because a large
portion of the SARS infections was associated with hospi-
tals, fear of SARS drove people out of hospitals and public
places. This fear and the change of people's behavior may
have significantly reduced the number of outpatients and
the transmission of many infectious diseases, including
scarlet fever. In fact, the SARS outbreak had a long-term
effect on the occurrences of scarlet fever. After the SARS
epidemic, the number of weekly scarlet fever reports was
often lower than the overall average until the first half of
2004.
Conclusion
The occurrences of scarlet fever in central Taiwan between
2000 and 2006 were primarily caused by six emm clones:
emm12 (40.0%), emm4 (23.2%), emm1 (16.3%), SmaI-
resistant  emm12* (10.3%), emm6 (3.8%) and emm22
(2.9%). Each emm clone had predominant PFGE geno-
type(s), and most minor genotypes within an emm cloneBMC Microbiology 2009, 9:115 http://www.biomedcentral.com/1471-2180/9/115
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emerged and quickly disappeared. The large fluctuation in
the number of scarlet fever cases during this time period
can be attributed to the shuffling of several prevalent emm
clones and to a SARS outbreak in 2003.
Methods
Epidemiological data and bacterial strains
Scarlet fever was a notifiable disease in Taiwan until 2007;
hospitals and clinics were obligated to report confirmed
or suspected cases to the county public health department
via a web-based Notifiable Diseases Reporting System
established by the Taiwan CDC in 2000. The hospitals
and clinics that reported scarlet fever cases were asked to
provide throat swab specimens or S. pyogenes isolates to
the regional laboratories of the Taiwan CDC for bacterial
examination and genotyping. Confirmed cases were those
in which S. pyogenes was isolated from the specimens. The
number of annual confirmed cases detected through the
Notifiable Diseases Reporting System was adjusted by
multiplying the number of reported cases and the rate of
positive specimens. S. pyogenes isolates used for character-
ization in this study were obtained directly from hospitals
located in central Taiwan through the Notifiable Diseases
Reporting System or were recovered from throat swab
specimens collected from hospitals and clinics through
the Notifiable Diseases Reporting System and the Sentinel
Physician Active Reporting System.
emm typing
The procedure developed by Beall and colleagues [5] was
used to prepare the emm DNA fragments from S. pyogenes
isolates for sequencing. The amplified DNA amplicons
and primer 1, 5'-TATT(C/G)GCTTAGAAAATTAA-3', were
sent to a local biotech company (Mission Biotech Corp.
Taipei, Taiwan) for DNA sequencing. The 5' emm
sequences (at least the first 240 bases) were subjected to a
BLAST comparison with those in the emm database (http:/
/www.cdc.gov/ncidod/biotech/strep/strepindex.htm;
accessed on April 20th, 2009) to determine emm type.
PFGE analysis
S. pyogenes isolates were subjected to PFGE analysis using
a previously described protocol [7]. All of the isolates were
analyzed by SmaI digestion. Isolates with DNA resistant to
SmaI digestion were analyzed with SgrAI. PFGE patterns
were recorded using a Kodak digital camera system
(Kodak Electrophoresis Documentation and Analysis Sys-
tem 290; Kodak; Rochester, NY, USA) with 1792 × 1200
pixels. The digital PFGE images were then analyzed using
BioNumerics software version 4.5 (Applied Maths, Kortr-
ijik, Belgium) and the DNA pattern for each isolate was
compared using the computer software. A unique PFGE
pattern (genotype) was defined if it contained one or
more DNA bands different from the others. The genetic
relatedness among isolates is presented in a dendrogram
built by clustering the PFGE patterns. The clustering anal-
ysis was performed using the UPGMA algorithm provided
in the BioNumerics software and the value of Dice pre-
dicted similarity of two patterns at settings of 1% optimi-
zation and 0.7% position tolerance.
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